RemedyRepack Inc. recalls Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack
Recalled March 1, 2017 · FDA recall D-0482-2017 · RemedyRepack
Hazard
Failed Dissolution Specifications · FDA Class II
Units
630 pills (21 bottles x 30 pills per HDPE bottle)
Sold at
Product was distributed to a sold customer in FL.
Description
Failed Dissolution Specifications
Product
Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02
Manufacturer(s)
RemedyRepack Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →